The distinctive nature of HER2-positive gastric cancers

被引：13
|
作者：
Marano, L. [1 ]
Roviello, F. [1 ]
机构：
[1] Univ Siena, Dept Med Surg & Neurosci, Unit Gen & Minimally Invas Surg, I-53100 Siena, Italy
来源：
EJSO | 2015年 / 41卷 / 03期
关键词：
HER2; EXPRESSION; RECEPTOR; PROTEIN;
D O I：
10.1016/j.ejso.2014.12.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：271 / 273
页数：3
相关论文
共 50 条
  • [21] HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer
    Akio Kaito
    Takeshi Kuwata
    Masanori Tokunaga
    Kohei Shitara
    Reo Sato
    Tetsuo Akimoto
    Takahiro Kinoshita
    World Journal of Clinical Cases, 2019, (15) : 1964 - 1977
  • [22] Mechanisms of resistance to trastuzumab in HER2-positive gastric cancer
    Zhifei Li
    Huan Zhao
    Huihui Hu
    Haili Shang
    Yongjing Ren
    Wenhui Qiu
    Hao Su
    Huifang Lyu
    Xiaobing Chen
    Chinese Journal of Cancer Research, 2024, 36 (03) : 306 - 321
  • [23] Treatment strategies for patients with HER2-positive gastric cancer
    Feixue Wang
    Yi Ba
    Cancer Biology & Medicine, 2023, 20 (12) : 934 - 941
  • [24] Clinicopathologic Features and Prognosis of HER2-Positive Gastric Cancer
    Kung, Ching-Yun
    Huang, Kuo-Hung
    Lin, Shih-Chieh
    Hung, Yi-Ping
    Chen, Ming-Huang
    Chao, Yee
    Lo, Su-Shun
    Wu, Chew-Wun
    Li, Anna Fen-Yau
    Fang, Wen-Liang
    Lan, Yuan-Tzu
    INTERNATIONAL SURGERY, 2024, 108 (02) : 68 - 77
  • [25] Mechanisms of resistance to trastuzumab in HER2-positive gastric cancer
    Li, Zhifei
    Zhao, Huan
    Hu, Huihui
    Shang, Haili
    Ren, Yongjing
    Qiu, Wenhui
    Su, Hao
    Lyu, Huifang
    Chen, Xiaobing
    CHINESE JOURNAL OF CANCER RESEARCH, 2024, 36 (03)
  • [26] Trastuzumab in HER2-Positive Metastatic Gastric CancerProfile Report
    Jamie D. Croxtall
    Kate McKeage
    BioDrugs, 2011, 25 : 257 - 259
  • [27] Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
    Park, Ji Soo
    Youn, Jong-Chan
    Shim, Chi Young
    Hong, Geu-Ru
    Lee, Choong-Kun
    Kim, Jee Hyung
    Park, Hyung Soon
    Heo, Su Jin
    Beom, Seung Hoon
    Kim, Hyo Song
    Rha, Sun Young
    Chung, Hyun Cheol
    Kang, Seok-Min
    Jung, Minkyu
    ONCOTARGET, 2017, 8 (37) : 61837 - 61845
  • [28] Challenges and future of HER2-positive gastric cancer therapy
    Ma, Chenzhe
    Wang, Xiao
    Guo, Jiwu
    Yang, Bo
    Li, Yumin
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [29] Trastuzumab biosimilar for HER2-positive breast and gastric carcinoma
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (09) : 482 - 483
  • [30] Trastuzumab deruxtecan for the treatment of HER2-positive gastric cancer
    Mishima, Saori
    Shitara, Kohei
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (07) : 825 - 830
12345